Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression
- 1 November 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (5) , 1929-1936
- https://doi.org/10.1016/s0002-9440(10)63551-1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- An efficient procedure for genotyping single nucleotide polymorphismsNucleic Acids Research, 2001
- Mutations in Calpain 3 Associated with Limb Girdle Muscular Dystrophy: Analysis by Molecular Modeling and by Mutation in m-CalpainBiophysical Journal, 2001
- Calpain Mutants with Increased Ca2+ Sensitivity and Implications for the Role of the C2-like DomainJournal of Biological Chemistry, 2001
- Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in MiceThe Journal of cell biology, 2000
- Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2AHuman Molecular Genetics, 2000
- Calpainopathy—A Survey of Mutations and PolymorphismsAmerican Journal of Human Genetics, 1999
- Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2AThe American Journal of Pathology, 1998
- Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblingsMuscle & Nerve, 1998
- Juvenile limb-girdle muscular dystrophyBrain, 1996
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995